| |
Agec
|
HT
|
DM
|
Age + HT
|
Age + DM
|
HT + DM
|
Age + HT + DM
|
---|
Single risk
|
TIA ( +)
|
73
|
60
|
27
|
53
|
25
|
21
|
21
|
TIA (-)
|
79
|
57
|
11
|
28
|
5
|
5
|
2
|
PPVd
|
48.0%
|
51.3%
|
71.1%
|
65.4%
|
83.3%
|
80.8%
|
91.3%
|
Single risk + ALDOA-Aba
|
TIA ( +)
|
53
|
47
|
21
|
41
|
20
|
17
|
17
|
TIA (-)
|
31
|
27
|
2
|
12
|
1
|
0
|
0
|
PPV
|
63.1%
|
63.5%
|
91.3%
|
77.4%
|
95.2%
|
100.0%
|
100.0%
|
Single risk + FH-Abb
|
TIA ( +)
|
39
|
33
|
16
|
29
|
14
|
14
|
13
|
TIA (-)
|
24
|
25
|
1
|
12
|
0
|
1
|
0
|
PPV
|
61.9%
|
56.9%
|
94.1%
|
70.7%
|
100.0%
|
93.3%
|
100.0%
|
Single risk + ALDOA-Ab + FH-Ab
|
TIA ( +)
|
32
|
29
|
15
|
25
|
14
|
13
|
13
|
TIA (-)
|
11
|
14
|
0
|
7
|
0
|
0
|
0
|
PPV
|
74.4%
|
67.4%
|
100.0%
|
78.1%
|
100.0%
|
100.0%
|
100.0%
|
- aADOLA-Ab, elevated ADOLA-Ab levels, > 14,869
- bFH-Ab, elevated FH-Ab levels, > 2,849
- cAge, ≥ 60
- dPPV, positive predictive value